Steve Harrison

Title: Steve Harrison: Innovator in Antimicrobial Disinfectant Technologies

Introduction

Steve Harrison is an accomplished inventor based in Naples, FL (US), known for his significant contributions to the field of antimicrobial disinfectants. With a total of 3 patents, he has focused on developing effective solutions for combating viruses, including the Covid-19 virus.

Latest Patents

Harrison's latest patents include innovative liquid antimicrobial disinfectant compositions that utilize iodine and copper complexes. These formulations are designed for the treatment of coronaviruses, specifically SARS-CoV-2, on skin and surfaces such as personal protective equipment (PPE). The disinfectants demonstrate a remarkable efficacy, achieving total eradication of the virus below detectable limits within 30 minutes, resulting in complete inactivation. Importantly, these compositions are non-toxic, safe, and non-irritating to skin and endogenous tissue, even with extended contact. They also exhibit extended antimicrobial and antiviral activity for over 24 hours, maintaining stability without precipitation or loss of efficacy for at least 12 months.

Career Highlights

Steve Harrison is currently associated with Clyra Medical Technologies, Inc., where he continues to innovate in the field of medical disinfectants. His work has been pivotal in improving health outcomes by providing safe and effective solutions for both personal and clinical use.

Collaborations

Harrison collaborates with notable professionals in his field, including Douglas J Morgan and Tanya Rhodes, contributing to the advancement of antimicrobial technologies.

Conclusion

Steve Harrison's innovative work in developing effective disinfectant technologies showcases his commitment to enhancing public health and safety. His contributions are vital in the ongoing fight against infectious diseases, particularly in the context of the Covid-19 pandemic.